Enhancement of oral bioavailability of drugs using lipid-based carriers: a meta-analysis study

References

• Nagai H, Kim YH. Cancer prevention from the perspective of global cancer burden patterns. J Thorac Dis. 2017;9(3):448–451.
   PubMed Web of Science ®Google Scholar
• Yehia R, Hathout RM, Attia DA, et al. Anti-tumor efficacy of an integrated methyl dihydrojasmonate transdermal microemulsion system targeting breast cancer cells: In vitro and in vivo studies. Colloids Surf B Biointerfaces. 2017;155:512–521.
   PubMed Web of Science ®Google Scholar
• Abdel-Hafez SM, Hathout RM, Sammour OA. Curcumin-loaded ultradeformable nanovesicles as a potential delivery system for breast cancer therapy. Colloids Surf B Biointerfaces. 2018;167:63–72.
   PubMed Web of Science ®Google Scholar
• Safwat S, Hathout RM, Ishak RA, et al. Augmented simvastatin cytotoxicity using optimized lipid nanocapsules: a potential for breast cancer treatment. J Liposome Res. 2017;27(1):1–10.
   PubMed Web of Science ®Google Scholar
• Mehanny M, Hathout RM, Geneidi AS, et al. Studying the effect of physically-adsorbed coating polymers on the cytotoxic activity of optimized bisdemethoxycurcumin loaded-PLGA nanoparticles. J Biomed Mater Res. 2017;105(5):1433–1445.
   Web of Science ®Google Scholar
• Abdelhamid HN, El-Bery HM, Metwally AA, et al. Synthesis of CdS-modified chitosan quantum dots for the drug delivery of Sesamol. Carbohydr Polym. 2019;214:90–99.
   PubMed Web of Science ®Google Scholar
• Yingchoncharoen P, Kalinowski DS, Richardson DR. Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come. Pharmacol Rev. 2016;68(3):701–787.
   PubMed Web of Science ®Google Scholar
• Olusanya TOB, Haj Ahmad RR, Ibegbu DM, et al. Liposomal drug delivery systems and anticancer drugs. Molecules. 2018;23(4):907.
   PubMed Web of Science ®Google Scholar
• Tagne JB, Kakumanu S, Ortiz D, et al. A nanoemulsion formulation of tamoxifen increases its efficacy in a breast cancer cell line. Mol Pharm. 2008;5(2):280–286.
   PubMed Web of Science ®Google Scholar
• Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128(1):305–310.
   PubMed Web of Science ®Google Scholar
• Haidich AB. Meta-analysis in medical research. Hippokratia. 2010;14(Suppl 1):29–37.
   PubMed Web of Science ®Google Scholar
• Mills EJ, Bansback N, Ghement I, et al. Multiple treatment comparison meta-analyses: a step forward into complexity. Clin Epidemiol. 2011;3:193–202.
   PubMedGoogle Scholar
• Fong SY, Brandl M, Bauer-Brandl A. Phospholipid-based solid drug formulations for oral bioavailability enhancement: a meta-analysis. Eur J Pharm Sci. 2015;80:89–110.
   PubMed Web of Science ®Google Scholar
• Nekkanti V, Rueda J, Wang Z, et al. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine. Int J Pharm. 2016;505(1–2):79–88.
   PubMedGoogle Scholar
• Nekkanti V, Wang Z, Betageri GV. Pharmacokinetic evaluation of improved oral bioavailability of valsartan: proliposomes versus self-nanoemulsifying drug delivery system. AAPS PharmSciTech. 2016;17(4):851–862.
   PubMed Web of Science ®Google Scholar
• Shah NM, Parikh J, Namdeo A, et al. Preparation, characterization and in vivo studies of proliposomes containing Cyclosporine A. J Nanosci Nanotechnol. 2006;6(9):2967–2973.
   PubMed Web of Science ®Google Scholar
• Nekkanti V, Rueda J, Wang Z, et al. Design, characterization, and in vivo pharmacokinetics of tacrolimus proliposomes. AAPS PharmSciTech. 2016;17(5):1019–1029.
   PubMed Web of Science ®Google Scholar
• Sun C, Wang J, Liu J, et al. Liquid proliposomes of nimodipine drug delivery system: preparation, characterization, and pharmacokinetics. AAPS PharmSciTech. 2013;14(1):332–338.
   PubMed Web of Science ®Google Scholar
• Velpula A, Jukanti R, Janga KY, et al. Proliposome powders for enhanced intestinal absorption and bioavailability of raloxifene hydrochloride: effect of surface charge. Drug Dev Ind Pharm. 2013;39(12):1895–1906.
   PubMed Web of Science ®Google Scholar
• Chen Y, Lu Y, Chen J, et al. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm. 2009;376(1–2):153–160.
   PubMed Web of Science ®Google Scholar
• Ghassemi S, Haeri A, Shahhosseini S, et al. Labrasol-enriched nanoliposomal formulation: novel approach to improve oral absorption of water-insoluble drug, carvedilol. AAPS PharmSciTech. 2018;19(7):2961–2970.
   PubMed Web of Science ®Google Scholar
• Li X, Yuan Q, Huang Y, et al. Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability. AAPS PharmSciTech. 2010;11(2):672–678.
   PubMed Web of Science ®Google Scholar
• Yi T, Wan J, Xu H, et al. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm. 2008;70(2):439–444.
   PubMed Web of Science ®Google Scholar
• Jakki R, Afzal SM, Kandadi P, et al. Development of a self-microemulsifying drug delivery system of domperidone: in vitro and in vivo characterization. Acta Pharm. 2013;63(2):241–251.
   PubMed Web of Science ®Google Scholar
• Shah N, Seth A, Balaraman R, et al. Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study. Drug Dev Ind Pharm. 2018;44(4):687–696.
   PubMed Web of Science ®Google Scholar
• Hu L, Wu H, Niu F, et al. Design of fenofibrate microemulsion for improved bioavailability. Int J Pharm. 2011;420(2):251–255.
   PubMedGoogle Scholar
• Mandal S. Microemulsion drug delivery system: design and development for oral bioavailability enhancement of lovastatin. South Afr Pharm J. 2011;78(3):44–50.
   Google Scholar
• Wei L, Sun P, Nie S, et al. Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm. 2005;31(8):785–794.
   PubMed Web of Science ®Google Scholar
• Li Y, Song J, Tian N, et al. Improving oral bioavailability of metformin hydrochloride using water-in-oil microemulsions and analysis of phase behavior after dilution. Int J Pharm. 2014;473(1–2):316–325.
   PubMed Web of Science ®Google Scholar
• Ong SG, Ming LC, Lee KS, et al. Influence of the encapsulation efficiency and size of liposome on the oral bioavailability of griseofulvin-loaded liposomes. Pharmaceutics. 2016;8(3):25.
   PubMed Web of Science ®Google Scholar
• Guan P, Lu Y, Qi J, et al. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Int J Nanomed. 2011;6:965–974.
   PubMed Web of Science ®Google Scholar
• Guo RX, Fu X, Chen J, et al. Preparation and characterization of microemulsions of myricetin for improving its antiproliferative and antioxidative activities and oral bioavailability. J Agric Food Chem. 2016;64(32):6286–6294.
   PubMed Web of Science ®Google Scholar
• Hu L, Jia Y, Niu F, et al. Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle. J Agric Food Chem. 2012;60(29):7137–7141.
   PubMed Web of Science ®Google Scholar
• Fagir W, Hathout RM, Sammour OA, et al. Self-microemulsifying systems of Finasteride with enhanced oral bioavailability: multivariate statistical evaluation, characterization, spray-drying and in vivo studies in human volunteers. Nanomedicine (Lond). 2015;10(22):3373–3389.
   PubMed Web of Science ®Google Scholar
• Hathout RM. Particulate systems in the enhancement of the antiglaucomatous drug pharmacodynamics: a meta-analysis study. ACS Omega. 2019;4(26):21909–21913.
   PubMed Web of Science ®Google Scholar
• Hathout RM, Woodman TJ. Applications of NMR in the characterization of pharmaceutical microemulsions. J Control Release. 2012;161(1):62–72.
   PubMed Web of Science ®Google Scholar
• Cherniakov I, Domb AJ, Hoffman A. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects. Expert Opin Drug Deliv. 2015;12(7):1121–1133.
   PubMed Web of Science ®Google Scholar
• Hathout RM, Mansour S, Mortada ND, et al. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech. 2007;8(1):1.
   PubMed Web of Science ®Google Scholar
• Van Slooten ML, Boerman O, Romoren K, et al. Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects. Biochim Biophys Acta. 2001;1530(2–3):134–145.
   PubMed Web of Science ®Google Scholar
• Daraee H, Etemadi A, Kouhi M, et al. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 2016;44(1):381–391.
   PubMed Web of Science ®Google Scholar
• Hathout RM, Woodman TJ, Mansour S, et al. Microemulsion formulations for the transdermal delivery of testosterone. Eur J Pharm Sci. 2010;40(3):188–196.
   PubMed Web of Science ®Google Scholar
• Wang K, Qi J, Weng T, et al. Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems. Int J Nanomedicine. 2014;9:4991–4999.
   PubMed Web of Science ®Google Scholar
• Ali KA, Mudassir J, Mohtar N, et al. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomed. 2013;8:2733–2744.
   PubMed Web of Science ®Google Scholar